Answers are grounded in this paper and cite their sources.
Artificial intelligence-derived imaging ageing clocks enable estimation of biological ageing from medical images. Yet meta-analytic quantification of the associations between imaging age gaps and both mortality and incident age-related diseases across multiple organs remains lacking. This study synthesised 40 eligible reports, of which 21 contributed to the meta-analysis. Meta-analyses showed that each 5-year increase in imaging age gap was associated with a higher hazard of all-cause mortality (HR 1.31, 95% CI 1.19–1.44), although heterogeneity was substantial ( I ² = 96.3%), with organ type and sample size contributing to heterogeneity. For cancer-specific mortality, the pooled HR was 1.06 (95% CI 0.96–1.18). Higher imaging age gaps were associated with incident dementia, stroke, heart failure, diabetes and hypertension, but not Parkinson’s disease. Imaging age gaps may support non-invasive risk stratification and long-term health management, but clinical translation requires standardisation, diverse external validation, interpretability, and evidence of clinical utility and equity.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: